Table 2.
Number of patients who received each study drug injection (full analysis set).
| Study drug injection, n (%) | ASP0113 (n = 246) | Placebo (n = 255) | Total (n = 501) |
|---|---|---|---|
| First injection | 246 (100) | 254 (99.6) | 500 (99.8) |
| Second injection | 207 (84.1) | 213 (83.5) | 420 (83.8) |
| Third injection | 182 (74.0) | 192 (75.3) | 374 (74.7) |
| Fourth injection | 173 (70.3) | 189 (74.1) | 362 (72.3) |
| Fifth injection | 148 (60.2) | 155 (60.8) | 303 (60.5) |
Patients received intramuscular doses of either ASP0113 or placebo on Days −14 to −3, 14 to 40, 60±5, 90±10, and 180±10.